Vagus nerve stimulation (VNS) is an invasive medical procedure used as an adjunctive treatment for intractable epilepsy and clinical depression. It is indicated for use as a last chance method, when other treatments have failed to work. VNS has been used to treat epilepsy since 1997. The depression indication was approved by the Food and Drug Administration (FDA) in 2005.
VNS uses an implant that sends tiny electric shocks to the vagus nerve. A connecting wire is run under the skin from the device to the vagus nerve in the left side of the neck. Three small leads are then carefully attached to the nerve. Implantation is usually accomplished within 1 to 2 hours. The mechanism of therapeutic action is unknown. **
The FDA's approval of VNS for treatment-resistant depression (TRD) in 2005 remains controversial. According to Dr. A. John Rush, vice chairman for research in the Department of Psychiatry at UT Southwestern Medical Center at Dallas, results of the VNS pilot study showed that 40 percent of the treated patients displayed at least a 50 percent or greater improvement in their condition, according to the Hamilton Depression Rating Scale.This finding does not take into account improvements over time in patients without the device. In the only randomized controlled trial VNS failed to perform any better when turned on than in otherwise similar implanted patients whose device was not turned on.*
The VNS device is made by Cyberonics Inc.
This article is licensed under the GNU Free Documentation License.
It uses material from the
"Vagus nerve stimulation".
Home Page • arts • business • computers • games • health • hospitals • home • kids & teens • news • physicians • recreation• reference • regional • science • shopping • society • sports • world